Amoxicillin And Clavulanate Potassium
Pricing Report NDC 43598-203-69

Latest NADAC: $0.09483 per ML · Effective Dec 21, 2016 · Est. package price $11.85 (125 ML)

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Amoxicillin And Clavulanate Potassium (NDC 43598-203-69) is $0.09483 per ML. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Dec 21, 2016.

As a provided by Dr Reddys Laboratories Inc, this medication is distributed in a 125 mL in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$0.09483
Per ML

Effective Date
Dec 21, 2016
Billable Units
125 ML
Estimated Package Price
$11.85
Data Status
As of Dec 28, 2016
C/I - Chain or Independent Pharmacy
Package NDC
Description
125 mL in 1 BOTTLE
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The NADAC was calculated based on package size.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Nov 2013, the NADAC wholesale price for (NDC ) has moved within a range of $0.08161 to $0.15939 per ML. Over this 3 years and 3 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.1088 - $0.1594
Market Volatility
46.54% Variance
Latest Trend
0.65%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Mar 01, 2017 $0.12501 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Mar 01, 2017 $0.09486 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Dec 21, 2016 $0.12420 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Dec 21, 2016 $0.08915 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Dec 21, 2016 $0.09483 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Nov 23, 2016 $0.10877 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Nov 23, 2016 $0.09034 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Nov 23, 2016 $0.09793 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Oct 19, 2016 $0.11457 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Oct 19, 2016 $0.09124 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Oct 19, 2016 $0.09170 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Sep 21, 2016 $0.11433 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 5: The NADAC was calculated based on package size.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: October 07, 2026